참고문헌 (42)

1. Hong, Seri, Won, Young-Joo, Lee, Jae Jun, Jung, Kyu-Won, Kong, Hyun-Joo, Im, Jeong-Soo, Seo, Hong Gwan. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018. Cancer research and treatment : official journal of Korean Cancer Association, vol.53, no.2, 301-315.

   상세보기

2. Siegel, Rebecca L., Miller, Kimberly D., Fedewa, Stacey A., Ahnen, Dennis J., Meester, Reinier G. S., Barzi, Afsaneh, Jemal, Ahmedin. Colorectal cancer statistics, 2017. CA: A Cancer Journal for Clinicians, vol.67, no.3, 177-193.

   상세보기

3. Heinemann, V., von Weikersthal, L.F., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S.E., Heintges, T., Lerchenmuller, C., Kahl, C., Seipelt, G., Kullmann, F., Stauch, M., Scheithauer, W., Hielscher, J., Scholz, M., Muller, S., Link, H., Niederle, N., Rost, A., Hoffkes, H.G., Moehler, M., Lindig, R.U., Modest, D.P., Rossius, L., Kirchner, T., Jung, A., Stintzing, S.. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. The Lancet. Oncology, vol.15, no.10, 1065-1075.

   상세보기

4. Van Cutsem, Eric, Köhne, Claus-Henning, Láng, István, Folprecht, Gunnar, Nowacki, Marek P., Cascinu, Stefano, Shchepotin, Igor, Maurel, Joan, Cunningham, David, Tejpar, Sabine, Schlichting, Michael, Zubel, Angela, Celik, Ilhan, Rougier, Philippe, Ciardiello, Fortunato. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.29, no.15, 2011-2019.

   상세보기

5. Wei, Spencer C., Duffy, Colm R., Allison, James P.. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer discovery, vol.8, no.9, 1069-1086.

   상세보기

6. Sinicrope, Frank A., Sargent, Daniel J.. Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.18, no.6, 1506-1512.

   상세보기

7. Comprehensive molecular characterization of human colon and rectal cancer. Nature, vol.487, no.7407, 330-337.

   상세보기

8. Toh, James W.T., de Souza, Paul, Lim, Stephanie H., Singh, Puneet, Chua, Wei, Ng, Weng, Spring, Kevin J.. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. Clinical colorectal cancer, vol.15, no.4, 285-291.

   상세보기

9. Le, Dung T., Uram, Jennifer N., Wang, Hao, Bartlett, Bjarne R., Kemberling, Holly, Eyring, Aleksandra D., Skora, Andrew D., Luber, Brandon S., Azad, Nilofer S., Laheru, Dan, Biedrzycki, Barbara, Donehower, Ross C., Zaheer, Atif, Fisher, George A., Crocenzi, Todd S., Lee, James J., Duffy, Steven M., Goldberg, Richard M., de la Chapelle, Albert, Koshiji, Minori, Bhaijee, Feriyl, Huebner, Thomas, Hruban, Ralph H., Wood, Laura D., Cuka, Nathan, Pardoll, Drew M., Papadopoulos, Nickolas, Kinzler, Kenneth W., Zhou, Shibin, Cornish, Toby C., Taube, Janis M., Anders, Robert A., Eshleman, James R., Vogelstein, Bert, Diaz Jr., Luis A.. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. The New England journal of medicine, vol.372, no.26, 2509-2520.

   상세보기

10. Le, Dung T., Kavan, Petr, Kim, Tae Won, Burge, Matthew E., Van Cutsem, Eric, Hara, Hiroki, Boland, Patrick McKay, Van Laethem, Jean-Luc, Geva, Ravit, Taniguchi, Hiroya, Crocenzi, Todd S., Sharma, Manish, Atreya, Chloe Evelyn, Diaz, Luis A., Liang, Li Wen, Marinello, Patricia, Dai, Tong, O'Neil, Bert H.. KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.36, no._suppl15, 3514-3514.

    상세보기

11. Le, Dung T., Kim, Tae Won, Van Cutsem, Eric, Geva, Ravit, Jäger, Dirk, Hara, Hiroki, Burge, Matthew, O’Neil, Bert, Kavan, Petr, Yoshino, Takayuki, Guimbaud, Rosine, Taniguchi, Hiroya, Elez, Elena, Al-Batran, Salah-Eddin, Boland, Patrick M., Crocenzi, Todd, Atreya, Chloe E., Cui, Yi, Dai, Tong, Marinello, Patricia, Diaz Jr, Luis A., André, Thierry. Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.38, no.1, 11-19.

    상세보기

12. Andre, Thierry, Shiu, Kai-Keen, Kim, Tae Won, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis J. A., Smith, Denis Michel, Garcia-Carbonero, Rocio, Benavides, Manuel, Gibbs, Peter, De La Fouchardiere, Christelle, Rivera, Fernando, Elez, Elena, Bendell, Johanna C., Le, Dung T., Yoshino, Takayuki, Yang, Ping, Farooqui, Mohammed Zulfiqar Husain, Marinello, Patricia, Diaz, Luis A.. Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.38, no.18, LBA4-LBA4.

    상세보기

13. Overman, Michael J, McDermott, Ray, Leach, Joseph L, Lonardi, Sara, Lenz, Heinz-Josef, Morse, Michael A, Desai, Jayesh, Hill, Andrew, Axelson, Michael, Moss, Rebecca A, Goldberg, Monica V, Cao, Z Alexander, Ledeine, Jean-Marie, Maglinte, Gregory A, Kopetz, Scott, André, Thierry. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. The Lancet. Oncology, vol.18, no.9, 1182-1191.

    상세보기

14. Overman, Michael J., Lonardi, Sara, Wong, Ka Yeung Mark, Lenz, Heinz-Josef, Gelsomino, Fabio, Aglietta, Massimo, Morse, Michael A., Van Cutsem, Eric, McDermott, Ray, Hill, Andrew, Sawyer, Michael B., Hendlisz, Alain, Neyns, Bart, Svrcek, Magali, Moss, Rebecca A., Ledeine, Jean-Marie, Cao, Z. Alexander, Kamble, Shital, Kopetz, Scott, André, Thierry. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.36, no.8, 773-779.

    상세보기

15. Lenz, Heinz-Josef, Van Cutsem, Eric, Luisa Limon, Maria, Wong, Ka Yeung Mark, Hendlisz, Alain, Aglietta, Massimo, García-Alfonso, Pilar, Neyns, Bart, Luppi, Gabriele, Cardin, Dana B., Dragovich, Tomislav, Shah, Usman, Abdullaev, Sandzhar, Gricar, Joseph, Ledeine, Jean-Marie, Overman, Michael James, Lonardi, Sara. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.40, no.2, 161-170.

    상세보기

16. Ali, Siraj Mahamed, Gay, Laurie M., Elvin, Julia Andrea, Vergilio, Jo-Anne, Ramkissoon, Shakti H., Suh, James, Severson, Eric Allan, Daniel, Sugganth, Killian, Jonathan Keith, Schrock, Alexa Betzig, Chung, Jon, Frampton, Garrett Michael, Fabrizio, David, Albacker, Lee A., Miller, Vincent A., Corona, Robert John, Ross, Jeffrey S.. MSI-high and MSI-stable colorectal carcinomas (CRC): A comprehensive genomic profiling (CGP) study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.36, no._suppl15, 3574-3574.

    상세보기

17. Akbay, Esra A., Koyama, Shohei, Carretero, Julian, Altabef, Abigail, Tchaicha, Jeremy H., Christensen, Camilla L., Mikse, Oliver R., Cherniack, Andrew D., Beauchamp, Ellen M., Pugh, Trevor J., Wilkerson, Matthew D., Fecci, Peter E., Butaney, Mohit, Reibel, Jacob B., Soucheray, Margaret, Cohoon, Travis J., Janne, Pasi A., Meyerson, Matthew, Hayes, D. Neil, Shapiro, Geoffrey I., Shimamura, Takeshi, Sholl, Lynette M., Rodig, Scott J., Freeman, Gordon J., Hammerman, Peter S., Dranoff, Glenn, Wong, Kwok-Kin. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors. Cancer discovery, vol.3, no.12, 1355-1363.

    상세보기

18. Yang, Hannah, Lee, Won Suk, Kong, So Jung, Kim, Chang Gon, Kim, Joo Hoon, Chang, Sei Kyung, Kim, Sewha, Kim, Gwangil, Chon, Hong Jae, Kim, Chan. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade. The Journal of clinical investigation, vol.129, no.10, 4350-4364.

    상세보기

19. Pozzi, Chiara, Cuomo, Alessandro, Spadoni, Ilaria, Magni, Elena, Silvola, Alessio, Conte, Alexia, Sigismund, Sara, Ravenda, Paola Simona, Bonaldi, Tiziana, Zampino, Maria Giulia, Cancelliere, Carlotta, Di Fiore, Pier Paolo, Bardelli, Alberto, Penna, Giuseppe, Rescigno, Maria. The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death. Nature medicine, vol.22, no.6, 624-631.

    상세보기

20. Fukuoka, Shota, Hara, Hiroki, Takahashi, Naoki, Kojima, Takashi, Kawazoe, Akihito, Asayama, Masako, Yoshii, Takako, Kotani, Daisuke, Tamura, Hitomi, Mikamoto, Yuichi, Hirano, Nami, Wakabayashi, Masashi, Nomura, Shogo, Sato, Akihiro, Kuwata, Takeshi, Togashi, Yosuke, Nishikawa, Hiroyoshi, Shitara, Kohei. Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.38, no.18, 2053-2061.

    상세보기

21. Cousin, Sophie, Cantarel, Coralie, Guegan, Jean-Philippe, Gomez-Roca, Carlos, Metges, Jean-Philippe, Adenis, Antoine, Pernot, Simon, Bellera, Carine, Kind, Michèle, Auzanneau, Céline, Le Loarer, Francois, Soubeyran, Isabelle, Bessede, Alban, Italiano, Antoine. Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.27, no.8, 2139-2147.

    상세보기

22. Bendell, Johanna C., Bang, Yung-Jue, Chee, Cheng Ean, Ryan, David P., McRee, Autumn Jackson, Chow, Laura Q., Desai, Jayesh, Wongchenko, Matthew, Yan, Yibing, Pitcher, Bethany, Foster, Paul, Cha, Edward, Grossman, William, Kim, Tae Won. A phase Ib study of safety and clinical activity of atezolizumab (A) and cobimetinib (C) in patients (pts) with metastatic colorectal cancer (mCRC).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.36, no._suppl4, 560-560.

    상세보기

23. Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. The Lancet. Oncology, vol.20, no.6, 849-861.

    상세보기

24. Pfirschke, C., Engblom, C., Rickelt, S., Cortez-Retamozo, V., Garris, C., Pucci, F., Yamazaki, T., Poirier-Colame, V., Newton, A., Redouane, Y., Lin, Y.J., Wojtkiewicz, G., Iwamoto, Y., Mino-Kenudson, M., Huynh, T.G., Hynes, R.O., Freeman, G.J., Kroemer, G., Zitvogel, L., Weissleder, R., Pittet, M.J.. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity, vol.44, no.2, 343-354.

    상세보기

25. Herting, Cameron J., Farren, Matthew R., Tong, Yan, Liu, Ziyue, O’Neil, Bert, Bekaii-Saab, Tanios, Noonan, Anne, McQuinn, Christopher, Mace, Thomas A., Shaib, Walid, Wu, Christina, El-Rayes, Bassel F., Shahda, Safi, Lesinski, Gregory B.. A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer immunology, immunotherapy : CII, vol.70, no.11, 3337-3348.

    상세보기

26. Ree, Anne Hansen, Hamre, Hanne, Kersten, Christian, Hofsli, Eva, Guren, Marianne Grønlie, Sorbye, Halfdan, Johansen, Christin, Negård, Anne, Flatmark, Kjersti, Meltzer, Sebastian. Repeat sequential oxaliplatin-based chemotherapy (FLOX) and nivolumab versus FLOX alone as first-line treatment of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Initial results from the randomized METIMMOX study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.39, no.15, 3556-3556.

    상세보기

27. Gong, Xiaomei, Li, Xuefei, Jiang, Tao, Xie, Huikang, Zhu, Zhengfei, Zhou, Fei, Zhou, Caicun. Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol.12, no.7, 1085-1097.

    상세보기

28. Sharabi, Andrew B., Nirschl, Christopher J., Kochel, Christina M., Nirschl, Thomas R., Francica, Brian J., Velarde, Esteban, Deweese, Theodore L., Drake, Charles G.. Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer immunology research, vol.3, no.4, 345-355.

    상세보기

29. Parikh, Aparna Raj, Clark, Jeffrey William, Wo, Jennifer Yon-Li, Yeap, Beow Y, Allen, Jill N., Blaszkowsky, Lawrence Scott, Ryan, David P., Giantonio, Bruce J., Weekes, Colin D., Zhu, Andrew X., Van Seventer, Emily E., Matlack, Lauren, Foreman, Bronwen, Ly, Leilana, Drapek, Lorraine C., Ting, David Tsai, Corcoran, Ryan Bruce, Hong, Theodore S.. A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.37, no.15, 3514-3514.

    상세보기

30. Parikh, Aparna R., Szabolcs, Annamaria, Allen, Jill N., Clark, Jeffrey W., Wo, Jennifer Y., Raabe, Michael, Thel, Hannah, Hoyos, David, Mehta, Arnav, Arshad, Sanya, Lieb, David J., Drapek, Lorraine C., Blaszkowsky, Lawrence S., Giantonio, Bruce J., Weekes, Colin D., Zhu, Andrew X., Goyal, Lipika, Nipp, Ryan D., Dubois, Jon S., van Seventer, Emily E., Foreman, Bronwen E., Matlack, Lauren E., Ly, Leilana, Meurer, Jessica A., Hacohen, Nir, Ryan, David P., Yeap, Beow Y., Corcoran, Ryan B., Greenbaum, Benjamin D., Ting, David T., Hong, Theodore S.. Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial. Nature cancer, vol.2, no.11, 1124-1135.

    상세보기

31. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-1718. 

32. Mathiak, Micaela, Rütten, Arno, Mangold, Elisabeth, Fischer, Hans-Peter, Ruzicka, Thomas, Friedl, Waltraut, Propping, Peter, Kruse, Roland. Loss of DNA Mismatch Repair Proteins in Skin Tumors From Patients With Muir-Torre Syndrome and MSH2 or MLH1 Germline Mutations: Establishment of Immunohistochemical Analysis as a Screening Test. The American journal of surgical pathology, vol.26, no.3, 338-343.

    상세보기

33. Lemery, Steven, Keegan, Patricia, Pazdur, Richard. First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication. The New England journal of medicine, vol.377, no.15, 1409-1412.

    상세보기

34. McGranahan, Nicholas, Furness, Andrew J. S., Rosenthal, Rachel, Ramskov, Sofie, Lyngaa, Rikke, Saini, Sunil Kumar, Jamal-Hanjani, Mariam, Wilson, Gareth A., Birkbak, Nicolai J., Hiley, Crispin T., Watkins, Thomas B. K., Shafi, Seema, Murugaesu, Nirupa, Mitter, Richard, Akarca, Ayse U., Linares, Joseph, Marafioti, Teresa, Henry, Jake Y., Van Allen, Eliezer M., Miao, Diana, Schilling, Bastian, Schadendorf, Dirk, Garraway, Levi A., Makarov, Vladimir, Rizvi, Naiyer A., Snyder, Alexandra, Hellmann, Matthew D., Merghoub, Taha, Wolchok, Jedd D., Shukla, Sachet A., Wu, Catherine J., Peggs, Karl S., Chan, Timothy A., Hadrup, Sine R., Quezada, Sergio A., Swanton, Charles. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science, vol.351, no.6280, 1463-1469.

    상세보기

35. Schrock, A.B., Ouyang, C., Sandhu, J., Sokol, E., Jin, D., Ross, J.S., Miller, V.A., Lim, D., Amanam, I., Chao, J., Catenacci, D., Cho, M., Braiteh, F., Klempner, S.J., Ali, S.M., Fakih, M.. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, vol.30, no.7, 1096-1103.

    상세보기

36. Chen, Eric X., Jonker, Derek J., Loree, Jonathan M., Kennecke, Hagen F., Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L., Wei, Alice C., Magoski, Nadine M., Tu, Dongsheng, O’Callaghan, Chris J.. Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer : The Canadian Cancer Trials Group CO.26 Study. JAMA oncology, vol.6, no.6, 1-8.

    상세보기

37. Loibl, Sibylle, Sinn, Bruno Valentin, Karn, Thomas, Untch, Michael, Sinn, Hans-Peter, Weber, Karsten Ernst, Hanusch, Claus, Huober, Jens Bodo, Staib, Peter, Lorenz, Ralf, Blohmer, Jens Uwe, Marmé, Frederik, Schmitt, Wolfgang D, Rhiem, Kerstin, van Mackelenbergh, Marion, Fasching, Peter A., Wu, Song, Higgs, Brandon W., Schneeweiss, Andreas, Denkert, Carsten. Exome analysis of oncogenic pathways and tumor mutational burden (TMB) in triple-negative breast cancer (TNBC): Results of the translational biomarker program of the neoadjuvant double-blind placebo controlled GeparNuevo trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.37, no.15, 509-509.

    상세보기

38. Yoon, Harry H., Jin, Zhaohui, Kour, Oudom, Kankeu Fonkoua, Lionel Aurelien, Shitara, Kohei, Gibson, Michael K., Prokop, Larry J., Moehler, Markus, Kang, Yoon-Koo, Shi, Qian, Ajani, Jaffer A.. Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer : Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials. JAMA oncology, vol.8, no.10, 1456-.

    상세보기

39. Ettinger, David S., Wood, Douglas E., Aisner, Dara L., Akerley, Wallace, Bauman, Jessica, Chirieac, Lucian R., D'Amico, Thomas A., DeCamp, Malcolm M., Dilling, Thomas J., Dobelbower, Michael, Doebele, Robert C., Govindan, Ramaswamy, Gubens, Matthew A., Hennon, Mark, Horn, Leora, Komaki, Ritsuko, Lackner, Rudy P., Lanuti, Michael, Leal, Ticiana A., Leisch, Leah J., Lilenbaum, Rogerio, Lin, Jules, Loo Jr, Billy W., Martins, Renato, Otterson, Gregory A., Reckamp, Karen, Riely, Gregory J., Schild, Steven E., Shapiro, Theresa A., Stevenson, James, Swanson, Scott J., Tauer, Kurt, Yang, Stephen C., Gregory, Kristina, Hughes, Miranda. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, vol.15, no.4, 504-535.

    상세보기

40. Fuchs, Charles S., Doi, Toshihiko, Jang, Raymond Woo-Jun, Muro, Kei, Satoh, Taroh, Machado, Manuela, Sun, Weijing, Jalal, Shadia Ibrahim, Shah, Manish A., Metges, Jean-Philippe, Garrido, Marcelo, Golan, Talia, Mandala, Mario, Wainberg, Zev A., Catenacci, Daniel V.T., Bang, Yung-Jue, Wang, Jiangdian, Koshiji, Minori, Dalal, Rita P., Yoon, Harry H.. KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.35, no._suppl15, 4003-4003.

    상세보기

41. Masarwy, Razan, Kampel, Liyona, Horowitz, Gilad, Gutfeld, Orit, Muhanna, Nidal. Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer : A Systematic Review and Meta-analysis. JAMA otolaryngology-- head & neck surgery, vol.147, no.10, 871-.

    상세보기

42. Endo, Eisei, Okayama, Hirokazu, Saito, Katsuharu, Nakajima, Shotaro, Yamada, Leo, Ujiie, Daisuke, Kase, Koji, Fujita, Shotaro, Endo, Hisahito, Sakamoto, Wataru, Saito, Motonobu, Saze, Zenichiro, Momma, Tomoyuki, Ohki, Shinji, Mimura, Kosaku, Kono, Koji. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair–Deficient/Microsatellite Instability-High Colorectal Cancer. Molecular cancer research, vol.18, no.9, 1402-1413.

    상세보기

저자의 다른 논문 :

이준 (2)